Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: an incentive for controlling agencies to prepare for future encounters of the kind.

Vanhee C, Francotte A, Janvier S, Deconinck E.

Drug Test Anal. 2019 Oct 30. doi: 10.1002/dta.2717. [Epub ahead of print] No abstract available.

PMID:
31667971
2.

Falsification of biotechnology drugs: current dangers and/or future disasters?

Janvier S, De Spiegeleer B, Vanhee C, Deconinck E.

J Pharm Biomed Anal. 2018 Nov 30;161:175-191. doi: 10.1016/j.jpba.2018.08.037. Epub 2018 Aug 20. Review.

PMID:
30165334
3.

Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market.

Janvier S, Cheyns K, Canfyn M, Goscinny S, De Spiegeleer B, Vanhee C, Deconinck E.

Talanta. 2018 Oct 1;188:795-807. doi: 10.1016/j.talanta.2018.06.023. Epub 2018 Jun 15.

PMID:
30029448
4.

Are injectable illegal polypeptide drugs safe? Case report demonstrating the presence of haemolytic Bacillus cereus in 2 illegal peptide drugs.

Janvier S, Wattijn E, Botteldoorn N, De Spiegeleer B, Deconinck E, Vanhee C.

Drug Test Anal. 2018 Apr;10(4):791-795. doi: 10.1002/dta.2304. Epub 2017 Dec 1. No abstract available.

PMID:
28941153
5.

Analysis of illegal peptide drugs via HILIC-DAD-MS.

Janvier S, De Sutter E, Wynendaele E, De Spiegeleer B, Vanhee C, Deconinck E.

Talanta. 2017 Nov 1;174:562-571. doi: 10.1016/j.talanta.2017.06.034. Epub 2017 Jun 13.

PMID:
28738623
6.

Assessment of dietary intake of 10 intense sweeteners by the Italian population.

Le Donne C, Mistura L, Goscinny S, Janvier S, Cuypers K, D'Addezio L, Sette S, Catasta G, Ferrari M, Piccinelli R, Van Loco J, Turrini A.

Food Chem Toxicol. 2017 Apr;102:186-197. doi: 10.1016/j.fct.2017.02.014. Epub 2017 Feb 16.

PMID:
28216168
7.

A simple dilute and shoot methodology for the identification and quantification of illegal insulin.

Vanhee C, Janvier S, Moens G, Deconinck E, Courselle P.

J Pharm Anal. 2016 Oct;6(5):326-334. doi: 10.1016/j.jpha.2016.04.006. Epub 2016 Apr 22.

8.

Identification of epidermal growth factor (EGF), in an unknown pharmaceutical preparation suspected to contain insulin like growth factor 1 (IGF-1).

Vanhee C, Janvier S, Moens G, Goscinny S, Courselle P, Deconinck E.

Drug Test Anal. 2017 May;9(5):831-837. doi: 10.1002/dta.2029. Epub 2016 Jul 8. No abstract available.

PMID:
27390261
9.

Low-calorie sweeteners in food and food supplements on the Italian market.

Janvier S, Goscinny S, Le Donne C, Van Loco J.

Food Addit Contam Part B Surveill. 2015;8(4):298-308. doi: 10.1080/19393210.2015.1094829.

PMID:
26406785
10.

Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies.

Vanhee C, Janvier S, Desmedt B, Moens G, Deconinck E, De Beer JO, Courselle P.

Talanta. 2015 Sep 1;142:1-10. doi: 10.1016/j.talanta.2015.04.022. Epub 2015 Apr 16.

PMID:
26003685
11.

Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals.

Felsovalyi F, Janvier S, Jouffray S, Soukiassian H, Mangiagalli P.

J Pharm Sci. 2012 Dec;101(12):4569-83. doi: 10.1002/jps.23328. Epub 2012 Sep 28.

PMID:
23023774
12.

Concise synthesis of an enantiopure bicyclic pyrazinone as constrained peptidomimetic building block.

Gembus V, Janvier S, Lecouvé JP, Vaysse-Ludot L, Brière JF, Levacher V.

Org Biomol Chem. 2012 Mar 14;10(10):2003-7. doi: 10.1039/c2ob06762e. Epub 2012 Feb 3.

PMID:
22302309
13.

HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C.

Blood. 2009 May 21;113(21):5176-85. doi: 10.1182/blood-2008-04-150342. Epub 2009 Mar 6.

14.

Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Ghez D, Lepelletier Y, Lambert S, Fourneau JM, Blot V, Janvier S, Arnulf B, van Endert PM, Heveker N, Pique C, Hermine O.

J Virol. 2006 Jul;80(14):6844-54.

15.

[Mystery upon the origin for the selection of AIDS-protective CCR5Delta32].

Janvier S, Heveker N.

Med Sci (Paris). 2005 Jun-Jul;21(6-7):577-9. French. No abstract available.

16.

[What is the interest of Klinefelter's syndrome for (child) psychiatrists?].

Kebers F, Janvier S, Colin A, Legros JJ, Ansseau M.

Encephale. 2002 May-Jun;28(3 Pt 1):260-5. French.

PMID:
12091788
17.

Use of the automated tail suspension test for the primary screening of psychotropic agents.

Porsolt RD, Chermat R, Lenègre A, Avril I, Janvier S, Stéru L.

Arch Int Pharmacodyn Ther. 1987 Jul;288(1):11-30.

PMID:
2889430

Supplemental Content

Loading ...
Support Center